Pharmabiz

Brii Bio announces positive end-of-treatment results from phase 2b ENRICH & ENHANCE studies to treat chronic hepatitis B

Brii Bio announces positive end-of-treatment results from phase 2b ENRICH & ENHANCE studies to treat chronic hepatitis B: Durham, North Carolina Monday, July 6, 2026, 18:00 Hrs [I ...
Pharmabiz

Arima Genomics enters distribution partnership with Active Motif for research-specific Hi-C sequencing kits and services

Arima Genomics enters distribution partnership with Active Motif for research-specific Hi-C sequencing kits and services: Carlsbad, California Monday, July 6, 2026, 17:00 Hrs [IST ...
Pharmabiz

Fischer Medical Ventures highlights strategic partnership as NYB.AI showcased at NVIDIA GTC Taiwan 2026

Fischer Medical Ventures highlights strategic partnership as NYB.AI showcased at NVIDIA GTC Taiwan 2026: Our Bureau, Mumbai Monday, July 6, 2026, 17:25 Hrs [IST] Fischer Medical V ...
Pharmabiz

Liver is increasingly coming under stress from unhealthy dietary habits: Dr Jitendra Singh

Liver is increasingly coming under stress from unhealthy dietary habits: Dr Jitendra Singh: Our Bureau, Mumbai Monday, July 6, 2026, 17:10 Hrs [IST] Union minister of state (indep ...
Pharmabiz

SK bioscience selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework

SK bioscience selected to lead the Gates Foundation-funded ROTOR project, establishing a global collaboration framework: Incheon, Republic of Korea Monday, July 6, 2026, 16:00 Hrs ...
Pharmabiz

Emcure Pharma arm Marcan to acquire remaining stake in Mantra Pharma

Emcure Pharma arm Marcan to acquire remaining stake in Mantra Pharma: Our Bureau, Mumbai Monday, July 6, 2026, 15:15 Hrs [IST] Emcure Pharmaceuticals announced that Marcan Pharmac ...
Pharmabiz

Public health advocacy group urges Centre to revise NLEM

The Working Group on Access to Medicines and Treatments has requested the Central government to urgently revise the National List of Essential Medicines (NLEM), pointing out that the World Health ...
Pharmabiz

Glenmark Pharma launches olanzapine for injection in US

Glenmark Pharmaceuticals Inc., USA announce the launch of olanzapine for injection, 10 mg/vial, single-dose vial. Glenmark’s olanzapine for injection is bioequivalent and therapeutically equivalent to ...
Pharmabiz

WHO launches first global database on the prevalence of sexually transmitted infections

The World Health Organization (WHO) has launched a new global database on the prevalence of sexually transmitted infections (STIs). The open-access database is the first global platform to provide ...
Pharmabiz

UK MHRA approves Novo Nordisk’s semaglutide to treat MASH in adults with moderate-to-advanced liver fibrosis

UK MHRA approves Novo Nordisk’s semaglutide to treat MASH in adults with moderate-to-advanced liver fibrosis: United Kingdom Monday, July 6, 2026, 13:00 Hrs [IST] The Medicines ...
Pharmabiz

US FDA seeks additional data from Ascelia Pharma’s Orviglance NDA

US FDA seeks additional data from Ascelia Pharma’s Orviglance NDA: Sweden Monday, July 6, 2026, 14:00 Hrs [IST] Ascelia Pharma AB (publ), a biotechnology company focused on impr ...
Pharmabiz

Oliva Therapeutics introduces Amerithroid, a naturally derived T3/T4 thyroid hormone replacement therapy

Oliva Therapeutics introduces Amerithroid, a naturally derived T3/T4 thyroid hormone replacement therapy: Ridgewood, New Jersey Monday, July 6, 2026, 12:00 Hrs [IST] Oliva Therape ...